Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pharmacokinetic Trial With a Topical Formulation of Tacrolimus in Healthy Subjects
NCT03673527Phase 1Completed
- Sponsor
- LEO Pharma
- Start
- Nov 2018
- Primary completion
- Feb 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of Tacrolimus Ointment 0.1% Iwaki, sponsored by LEO Pharma. Primary endpoints: Area Under the Plasma Concentration-Time Curve From Time Zero to Twelve Hours at Day 14 and Maximum Observed Drug Concentration at Day 14. Started Nov 2018; status: completed.
02
Drugs
Tacrolimus Ointment 0.1% Iwaki
Beyond the preview
Go deeper on NCT03673527.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03673527.